Skip to main content
SpringerLink
Log in

Removal of silicon, aluminum and beta2-Microglobulin in chronic haemodialysis patients

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

One hundred outpatients on chronic haemodialysis with polymethylmethacrylate (PMMA) membrane dialyzer were randomly chosen. A control group of 100 likewise randomly chosen outpatients were treated with cuprophane membrane dialyzer. In both groups the treatments lasted for one year.

Comparison of the test results revealed that Si, Al and β2M.G levels could be reduced in patients on chronic HD with PMMA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berkyne, G., Dudek, E., Alder, A. J., Rubin, J. E., Seidman, M: Silicon metabolism: The basic facts in renal failure.Kidney Int., 28, Suppl. 17, 175 (1985).

    Google Scholar 

  2. Mauras, Y., Riberi, P, Cartier, F., Allain, P.: Increase in blood silicon concentration in patients with renal failure.Biomedicine, 33, 228 (1980).

    PubMed  CAS  Google Scholar 

  3. Hosokawa, S., Imai, T., Okumura, T., Tomoyoshi T., Kawamura, J., Sawanishi, K., Yoshida, O.: Aluminum transfer during hemodialysis.Trace Elements in Medicine, 1, 59 (1984).

    Google Scholar 

  4. Alfrey, A. C., Hegg, A. B. S., Craswell, P.: Metabolism and toxicity of aluminum in renal failure.Am. J. Clin. Nutr., 33, 1509 (1980).

    PubMed  CAS  Google Scholar 

  5. Vandenbroucke, J. M., Huaux, J. P., Guillaume, T. H., Noel, H., Maldague, B., Strihow, C. V.: Capsular, synovial and bone amyloidosis: Complication of long-term haemodialysis.Proc. EDTA-ERA, 22, 136 (1985).

    Google Scholar 

  6. Hauglustain, D., Van Damme, B., Daenen, P., Michelsin, P.: Silicon nephropathy: A possible occupational hazard.Nephron, 26, 219 (1980).

    Article  Google Scholar 

  7. Bommer, J., Waldherr, R., Rise, E.: Silicon stage disease in long-term haemodialysis patients.Contr. Nephrol., 36, 115 (1983).

    CAS  Google Scholar 

  8. Kolev, K., Doitschinov, D., Todorov, D.: Morphologic alteration in the kidney by silicons.Medna Lav., 61, 205 (1970).

    CAS  Google Scholar 

  9. Hershey, C. O., Ricanai, E. S., Hershey, L. A., Varmes, A. W., Lavin, P. J. M., Strain, W. H.: Silicon as a potential uremic neurotoxin: Trace element analysis in patients with renal failure.Neurology, 33, 786 (1983).

    PubMed  CAS  Google Scholar 

  10. Hosokawa, S., Koike, T., Nishitani, H., Nishio, T., Umemura, K., Tomoyoshi, T., Sawanishi, K., Yoshida, O.: Relationship between serum aluminum levels and anemia in chronic hemodialysis patients. In: K. Nose, C. Kjellstrand, P. Ivanovich (eds): Progress in Artificial Organs. ISAO Press, Cleveland 1986, pp. 165–169.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Utano National Hospital, Kyoto, Japan

    S. Hosokawa

  2. Kyoto University Hospital, Kyoto, Japan

    O. Yoshida

Authors
  1. S. Hosokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hosokawa, S., Yoshida, O. Removal of silicon, aluminum and beta2-Microglobulin in chronic haemodialysis patients. International Urology and Nephrology 23, 281–284 (1991). https://doi.org/10.1007/BF02550425

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550425

Keywords

Search

Navigation